**Education and Professional Experience:** 1997–2002: Undergraduate study in Clinical Medicine at Sun Yat-sen University (North Campus), awarded Bachelor's degree. 2002–2007: Combined Master's and Doctoral program in Reproductive Medicine at the First Affiliated Hospital of Sun Yat-sen University, awarded Doctorate degree. July 2007: Employed at the Reproductive Center, First Affiliated Hospital of Sun Yat-sen University. December 2010: Appointed Attending Physician. December 2015: Appointed Associate Chief Physician. **Social Appointments:** 1. Deputy Head of the Ethics Group, Reproductive Medicine Branch, Guangdong Medical Association. 2. Member of the Ethics Professional Group, Guangdong Provincial Quality Control Center for Human Assisted Reproductive Technology. 3. Member of the First Committee, Multidisciplinary Collaborative Professional Committee for Gynecological Oncology, Guangdong Health Management Association. 4. Member of the Tumor Reproductive Specialty Group, Family Planning Branch, Chinese Medical Association. 5. Youth Committee Member, Reproductive Medicine and Reproductive Ethics Branch, China Eugenics Science Association. **Publications:** 1. Endometriosis does not seem to be an influencing factor of hypertensive disorders of pregnancy in IVF/ICSI cycles. Reprod Biol Endocrinol. 2022 Mar 25;20(1):57. doi: 10.1186/s12958-022-00922-5. Corresponding author (IF: 5.211). 2. Comparison of Hysterosalpingography With Laparoscopy in the Diagnosis of Tubal Factor of Female Infertility. Front. Med. 2021 Oct 29;8:720401. https://doi.org/10.3389/fmed.2021.720401. Corresponding author (IF: 5.09). 3. A Novel Nomogram for Individualized Gonadotropin Starting Dose in GnRH Antagonist Protocol. Frontiers in Endocrinology. 2021 Sep 14;12:688654. First author (IF: 5.555). 4. Serum levels of cancer antigen 125 before hormone replacement therapy are not associated with clinical outcome of frozen embryo transfer in women with adenomyosis. J Int Med Res. 2021 Apr;49(4):3000605211005878. Co-author (IF: 1.671). 5. Low basal serum testosterone level is detrimental to the embryo implantation in the patients with severe endometriosis. Journal of Obstetrics and Gynaecology Research. 2021, Jun;47(6):2166-2174. Corresponding author (IF: 1.73). 6. Protective Effects of Reduced Glutathione and Ulinastatin on Xeno-transplanted Human Ovarian Tissue Against Ischemia and Reperfusion Injury. Cell transplantation. Jan-Dec 2021;30:963689721997151. Co-author (IF: 4.064). 7. Mechanism study of breviscapine protecting testicular injury in type I diabetic rats. Journal of Sun Yat-sen University (Medical Sciences). 2020, 41(2):260-267. Corresponding author. 8. Study on angiogenesis of human frozen-thawed ovarian tissue after xeno-heterotopic transplantation. Chinese Journal of Maternal and Child Health. 2020;31(23):213-218. Corresponding author. 9. Analysis of clinical outcomes of single embryo transfer. Journal of Sun Yat-sen University (Medical Sciences). 2019;40(5):754-760. Corresponding author. 10. Study on cut-off values of anti-Müllerian hormone levels in women with normal menstrual cycles and polycystic ovary syndrome. Chinese Journal of Maternal and Child Health. 2019;10(4):21-24. First author. 11. Study on the willingness and influencing factors of second-child fertility in women with secondary infertility. Chinese Journal of Reproduction and Contraception. 2019;39(2):139-142. Corresponding author. 12. Protective effects of reduced glutathione and ulinastatin on xenografted frozen-thawed human ovarian tissue. Chinese Journal of Tissue Engineering Research. 2019;23(7):1084-1089. Corresponding author. 13. Human ovarian tissue xenografted in aseptically wounded mice to conserve follicles. Int J Clin Exp Med 2017;10(9):13482-13490. Corresponding author (IF: 0.181). 14. Pathological changes of human ovarian tissue after xenografting. Chinese Journal of Health Laboratory Technology. 2016, 26(4):463-465. Corresponding author. 15. Basal serum testosterone levels correlate with ovarian reserve and ovarian response in cycling women undergoing in vitro fertilization. Gynecol Endocrinol. 2016, 32(1):51-54. Corresponding author (IF: 2.26). 16. Clinical analysis of 158 cases of dysfunctional uterine bleeding. Chinese Journal of Practical Gynecology and Obstetrics. 2015, 31(7):645-648. First author. 17. Breviscapine intervention on the expression of proliferating cell nuclear antigen and c-fos in testicular tissue of diabetic model rats. Chinese Journal of Tissue Engineering Research. 2014, 19(18):2917-2922. Corresponding author. 18. Comparison of fertilization outcome between microdrop and open insemination methods in non-male factor IVF patients. Syst Biol Reprod Med. 2014;60(3):165-70. First author (IF: 3.061). 19. Modified vitrification method for cryopreservation of human ovarian tissues. Chinese Medical Journal. 2007; 120(2):110-114. First author (IF: 2.628). 20. Study on two ultra-low temperature cryopreservation methods for human ovarian tissue. Journal of Sun Yat-sen University (Medical Sciences). 2006, 27(6):104-108. First author. **Monograph:** *Case Discussions on Difficult Issues in Assisted Reproductive Technology*. People's Military Medical Press, April 2014. Editor. **Other Major Work Achievements (e.g., Awards):** Long-term engagement in clinical research on assisted reproductive technology and infertility. Has led multiple projects including the National Natural Science Foundation of China, Guangdong Provincial Natural Science Foundation, and university-level funds. Participated in several provincial and ministerial research funds such as 973, 863, and industry funds. Published over 30 academic papers as first author/corresponding author. Conducted in-depth basic research on cryopreservation and application of human ovarian tissue, as well as human follicle growth and differentiation. One of the earliest researchers in China to perform ultra-low temperature cryopreservation of human ovarian tissue for fertility preservation.